Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study
Authors:
- Robert A. SweetRSRobert A. Sweet
- the National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group*TGthe National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group*
Open Access
- 10 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 133 (4) , 1155-1162
Abstract
Determining the genetic architecture of late onset Alzheimer’s disease remains an important research objective. One approach to the identification of novel genetic variants contributing to the disease is the classification of biologically meaningful subgroups within the larger late-onset Alzheimer’s disease phenotype. The occurrence of psychotic symptoms in patients with late-onset Alzheimer’s disease may identify one such group. We attempted to establish methods for the reliable assessment of psychotic symptoms in a large, geographically dispersed collection of families, multiply affected with late onset Alzheimer’s disease, who were participants in the larger National Institute on Aging Late Onset Alzheimer’s Disease Family Study; and to characterize the correlates and familial aggregation of psychosis within this cohort. We found that reliable assessments of psychotic symptoms during in-person or phone interviews were readily implemented. The presence of psychosis in late onset Alzheimer’s disease was significantly associated with degree of cognitive impairment, and significantly, albeit modestly, correlated with the severity of other behavioural symptoms. Psychosis significantly aggregated within late onset Alzheimer’s disease families suggesting that it may identify a genetically determined subgroup. Future studies should examine the linkage and association of psychosis with genetic variation within these families.Keywords
This publication has 40 references indexed in Scilit:
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- SORL1 is genetically associated with Alzheimer disease in a Japanese populationNeuroscience Letters, 2009
- Examination of the current top candidate genes for AD in a genome-wide association studyMolecular Psychiatry, 2009
- Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family StudyArchives of Neurology, 2008
- SORL1 variants and risk of late-onset Alzheimer’s diseaseNeurobiology of Disease, 2008
- Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007
- The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseNature Genetics, 2007
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982